Vanda Pharmaceuticals Announces Participation in the Stifel 2025 Healthcare Conference
Vanda Pharmaceuticals (Nasdaq: VNDA) will participate in the Stifel 2025 Healthcare Conference in New York City on Wednesday, November 12, 2025.
A corporate presentation is scheduled for 4:40 p.m. Eastern Time and will be accessible live on Vanda's investor website via the Investors tab under Recent Events. Attendees are advised to arrive at the conference website at least 15 minutes early to register and download any required software or materials. Archived conference links will be available on Vanda's website for approximately 30 days after the event.
Vanda Pharmaceuticals (Nasdaq: VNDA) parteciperà alla Stifel 2025 Healthcare Conference a New York City mercoledì 12 novembre 2025.
Una presentazione aziendale è prevista per le 16:40 ora della costa orientale e sarà visibile in diretta sul sito degli investitori di Vanda, tramite la scheda Investors in Recent Events. Si consiglia ai partecipanti di accedere al sito della conferenza almeno 15 minuti prima per registrarsi e scaricare eventuale software o materiali richiesti. I link della conferenza archiviata saranno disponibili sul sito di Vanda per circa 30 giorni dopo l'evento.
Vanda Pharmaceuticals (Nasdaq: VNDA) participará en la Stifel 2025 Healthcare Conference en la ciudad de Nueva York el miércoles 12 de noviembre de 2025.
Se ha programado una presentación corporativa para las 4:40 p.m. Hora del Este y estará disponible en vivo en el sitio web de inversores de Vanda, a través de la pestaña Investors en Recent Events. Se recomienda a los asistentes que lleguen al sitio de la conferencia al menos 15 minutos antes para registrarse y descargar cualquier software o material necesario. Los enlaces de conferencias archivadas estarán disponibles en el sitio web de Vanda durante aproximadamente 30 días después del evento.
Vanda Pharmaceuticals (Nasdaq: VNDA)은 뉴욕시에서 열리는 Stifel 2025 Healthcare Conference에 2025년 11월 12일 수요일 참가합니다.
기업 발표는 동부 표준시 기준 오후 4시 40분에 예정되어 있으며, Vanda의 투자자 웹사이트의 Investors 탭 아래의 Recent Events에서 생방송으로 시청할 수 있습니다. 참석자는 등록 및 필요한 소프트웨어나 자료를 다운로드하기 위해 컨퍼런스 웹사이트에 최소 15분 일찍 도착하는 것이 좋습니다. 행사 후 약 30일 동안 Vanda 웹사이트에서 아카이브 컨퍼런스 링크를 이용할 수 있습니다.
Vanda Pharmaceuticals (Nasdaq : VNDA) participera à la Stifel 2025 Healthcare Conference à New York le mercredi 12 novembre 2025.
Une présentation d’entreprise est prévue à 16 h 40, heure de l’Est, et sera disponible en direct sur le site des investisseurs de Vanda via l’onglet Investors sous Recent Events. Il est recommandé aux participants d’arriver sur le site de la conférence au moins 15 minutes avant pour s’enregistrer et télécharger tout logiciel ou tout matériel requis. Les liens des conférences archivées seront disponibles sur le site de Vanda pendant environ 30 jours après l’événement.
Vanda Pharmaceuticals (Nasdaq: VNDA) wird an der Stifel 2025 Healthcare Conference in New York City am Mittwoch, dem 12. November 2025, teilnehmen.
Eine Firmenpräsentation ist für 16:40 Uhr Eastern Time geplant und wird live auf der Investoren-Website von Vanda über den Reiter Investors unter Recent Events verfügbar sein. Den Teilnehmern wird empfohlen, mindestens 15 Minuten früher auf der Konferenz-Website zu erscheinen, um sich zu registrieren und ggf. erforderliche Software oder Materialien herunterzuladen. Archivierte Konferenzlinks stehen auf der Website von Vanda ungefähr 30 Tage nach der Veranstaltung zur Verfügung.
Vanda Pharmaceuticals (Nasdaq: VNDA) ستشارك في مؤتمر ستايفل للرعاية الصحية 2025 في مدينة نيويورك يوم الأربعاء 12 نوفمبر 2025.
من المقرر أن تكون هناك عرض تقديمي للشركة في الساعة 4:40 مساءً بالتوقيت الشرقي، وسيكون متاحاً مباشرةً على موقع المستثمرين الخاص بفاندَا عبر تبويب Investors ضمن Recent Events. يُنصح المشاركون بالوصول إلى موقع المؤتمر قبل التسجيل وتنزيل أي برامج أو مواد مطلوبة لمدة 15 دقيقة على الأقل. ستتوفر روابط المؤتمر المؤرشَفة على موقع فاندَا لمدة تقارب 30 يوماً بعد الحدث.
- None.
- None.
The corporate presentation given at the Stifel conference may be accessed live on Vanda's corporate website, www.vandapharma.com. Investors should click on the Investors tab and follow the links under Recent Events. Investors are advised to go to the conference websites at least 15 minutes early to register, download, and install any necessary software or presentations. Links to the archived conferences will be available on Vanda's website for a period of approximately 30 days.
About Vanda Pharmaceuticals Inc.
Vanda is a leading global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the lives of patients. For more on Vanda Pharmaceuticals Inc., please visit www.vandapharma.com and follow us on X @vandapharma.
Corporate Contact:
Kevin Moran
Senior Vice President, Chief Financial Officer and Treasurer
Vanda Pharmaceuticals Inc.
202-734-3400
pr@vandapharma.com
Jim Golden / Jack Kelleher / Dan Moore
Collected Strategies
VANDA-CS@collectedstrategies.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/vanda-pharmaceuticals-announces-participation-in-the-stifel-2025-healthcare-conference-302606237.html
SOURCE Vanda Pharmaceuticals Inc.